INSIGHT MOLECULAR DIAGNOSTICS INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2024)
$4.40M
Revenue
$-60.78M
Net Income
-3.20
EPS (Diluted)
$-42.87M
Free Cash Flow
Profitability
Gross Margin
54.73%
Operating Margin
-1392.91%
Net Profit Margin
-1380.69%
EBITDA
$-59.15M
Returns & Efficiency
Return on Assets (ROA)
-138.33%
Return on Equity (ROE)
-
Gross Profit
$2.41M
Operating Income
$-61.32M
Financial Health
Total Assets
$43.94M
Total Debt
-
Debt to Equity
-x
Current Ratio
2.79
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$-3.20
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217 |
| Phone | 949-409-7600 |
| Incorporated | CA, US |
| EIN | 271041563 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 32.03M |
| Stockholders' Equity | $-9.20M |
| Cash & Equivalents | $18.69M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-26
Local
SCHEDULE 13D/A
Amended Schedule 13D
Amendment to Schedule 13D
Filed: 2026-02-12
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-12
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-12
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-11
Local
424B5
Prospectus Supplement
Prospectus supplement filed under Rule 424(b)(5)
Filed: 2026-02-11
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-10
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-11
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-05-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-12
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-03-24
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-12
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-09-25
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-08
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-15
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
54.7%
Operating Margin
-1392.9%
Net Margin
-1380.7%
ROE
-
ROA
-138.3%
Leverage & Liquidity
Debt to Equity
-
Current Ratio
2.79
Total Debt
-
Total Assets
$43.94M
Stockholders' Equity
$-9.20M
Income Statement (FY 2024)
Revenue
$4.40M
Gross Profit
$2.41M
Operating Income
$-61.32M
Net Income
$-60.78M
EPS (Diluted)
$-3.20
Cash Flow (FY 2024)
Free Cash Flow
$-42.87M
Cash & Equivalents
$18.69M
Revenue Growth
134.0%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...